Showing results (71-80 of 110) with videos related to
Sort By:
Pageof 11
Journal of Assisted Reproduction and Genetics|June 24, 2017
Potential therapeutic applications of human anti-Müllerian hormone (AMH) analogues in reproductive medicineVitaly A Kushnir, David B Seifer, David H Barad, et al.Reproductive Biology and Endocrinology : RB&E|April 27, 2020
Do state insurance mandates alter ICSI utilization?Pavel Zagadailov, David B Seifer, He Shan, et al.Journal of Assisted Reproduction and Genetics|January 19, 2015
Knowledge of ovarian reserve and reproductive choicesErum Azhar, David B Seifer, Katherine Melzer, et al.Obstetrics and Gynecology|April 30, 2002
Practice patterns among board-certified reproductive endocrinologists regarding high-order multiple gestations: a united states national surveyDoreen L Hock, David B Seifer, Eftichia Kontopoulos, et al.The Journal of Clinical Endocrinology and Metabolism|February 12, 2002
Brain-derived neurotrophic factor: a novel human ovarian follicular proteinDavid B Seifer, Bo Feng, Robert M Shelden, et al.Fertility and Sterility|June 12, 2002
DNA microarray analysis of the expression profiles of luteinized granulosa cells as a function of ovarian reserveKhew-Voon Chin, David B Seifer, Bo Feng, et al.Fertility and Sterility|August 4, 2014
Assisted hatching and intracytoplasmic sperm injection are not associated with improved outcomes in assisted reproduction cycles for diminished ovarian reserve: an analysis of cycles in the United States from 2004 to 2011Samantha F Butts, Carter Owen, Monica Mainigi, et al.Nutrients|March 29, 2017
Vitamin D Decreases Serum VEGF Correlating with Clinical Improvement in Vitamin D-Deficient Women with PCOS: A Randomized Placebo-Controlled TrialMohamad Irani, David B Seifer, Richard V Grazi, et al.Reproductive Biology and Endocrinology : RB&E|August 4, 2022
Impact of in vitro fertilization state mandates for third party insurance coverage in the United States: a review and critical assessmentBenjamin J Peipert, Melissa N Montoya, Bronwyn S Bedrick, et al.Fertility and Sterility|May 21, 2013
Transforming growth factor-β1 and its receptor soluble endoglin are altered in polycystic ovary syndrome during controlled ovarian stimulationReshef Tal, David B Seifer, Aya Shohat-Tal, et al.Pageof 11